US Stock MarketDetailed Quotes

IRWD Ironwood Pharmaceuticals

Watchlist
  • 8.060
  • +0.140+1.77%
Close Apr 22 16:00 ET
  • 8.060
  • 0.0000.00%
Pre 08:00 ET
1.26BMarket Cap-1249P/E (TTM)

Ironwood Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
7.83%442.74M
9.66%117.55M
4.70%113.74M
10.44%107.38M
6.70%104.06M
-0.76%410.6M
-8.48%107.2M
4.71%108.64M
-6.54%97.23M
9.77%97.53M
Operating revenue
7.83%442.74M
9.66%117.55M
4.70%113.74M
10.44%107.38M
6.70%104.06M
-0.76%410.6M
-8.48%107.2M
4.71%108.64M
-6.54%97.23M
9.77%97.53M
Cost of revenue
Gross profit
Operating expense
71.22%274.4M
91.43%74.34M
71.87%69.03M
109.40%87.06M
10.79%43.96M
-11.72%160.26M
-35.85%38.84M
3.92%40.16M
6.02%41.58M
-8.00%39.68M
Selling and administrative expenses
36.48%158.31M
36.20%38.67M
25.95%36.05M
74.23%52.48M
7.82%31.12M
4.37%115.99M
-1.04%28.39M
3.16%28.62M
11.36%30.12M
4.37%28.86M
Research and development costs
162.25%116.09M
241.53%35.68M
185.71%32.99M
201.93%34.58M
18.71%12.85M
-37.13%44.27M
-67.20%10.45M
5.85%11.55M
-5.85%11.45M
-30.11%10.82M
Operating profit
-32.76%168.34M
-36.79%43.21M
-34.71%44.71M
-63.49%20.32M
3.89%60.1M
7.80%250.34M
20.80%68.36M
5.18%68.47M
-14.13%55.66M
26.55%57.85M
Net non-operating interest income expense
-239.67%-2.66M
-284.41%-7.23M
-730.63%-8.09M
681.75%6.92M
372.15%5.75M
106.25%1.9M
150.44%3.92M
116.74%1.28M
84.27%-1.19M
71.59%-2.11M
Non-operating interest income
99.67%18.97M
-78.08%1.19M
-37.73%1.75M
760.22%8.76M
3,061.74%7.27M
1,208.68%9.5M
2,925.56%5.45M
1,476.97%2.81M
491.86%1.02M
17.35%230K
Non-operating interest expense
184.67%21.63M
223.43%9.64M
738.58%9.43M
-20.70%1.34M
-37.64%1.13M
-75.61%7.6M
-67.58%2.98M
-84.83%1.13M
-76.90%1.69M
-75.04%1.8M
Total other finance cost
----
----
1.50%405K
-3.29%499K
-25.14%402K
----
----
-6.34%399K
25.24%516K
34.92%537K
Other net income (expense)
-612,048.90%-1.11B
-31,127.78%-5.62M
-3,202.65%-4.69M
-161,935.24%-1.1B
-97.40%19K
116.05%182K
99.30%-18K
-93.25%151K
76.39%-681K
-64.89%730K
Gain on sale of security
-89.56%19K
--0
----
----
-97.40%19K
115.45%182K
99.30%-18K
-93.02%151K
78.49%-681K
-69.46%730K
Special income (charges)
---1.11B
---5.62M
---4.69M
---1.1B
----
--0
--0
--0
--0
----
-Less:Restructuring and merger&acquisition
--18.32M
--621K
--4.69M
--13.01M
----
--0
--0
--0
--0
----
-Less:Other special charges
--1.1B
--5M
----
--1.09B
----
----
----
----
----
----
Income before tax
-475.59%-948.07M
-57.99%30.36M
-54.32%31.93M
-2,100.97%-1.08B
16.64%65.86M
25.80%252.42M
56.23%72.27M
17.15%69.91M
-1.08%53.79M
39.91%56.47M
Income tax
7.93%83.49M
37.21%32.11M
-8.21%17.98M
-20.65%13.26M
14.06%20.15M
123.60%77.36M
379.37%23.4M
411.89%19.59M
104.96%16.71M
3,988.89%17.66M
Net income
-689.24%-1.03B
-103.57%-1.75M
-72.28%13.95M
-3,038.18%-1.09B
17.82%45.71M
-66.87%175.07M
18.11%48.87M
-9.90%50.32M
-90.52%37.08M
-2.82%38.8M
Net income continuous Operations
-689.24%-1.03B
-103.57%-1.75M
-72.28%13.95M
-3,038.18%-1.09B
17.82%45.71M
-66.87%175.07M
18.11%48.87M
-9.90%50.32M
-90.52%37.08M
-2.82%38.8M
Minority interest income
-29.32M
-658K
-1.37M
-27.29M
0
0
0
0
Net income attributable to the parent company
-672.50%-1B
-102.22%-1.09M
-69.55%15.32M
-2,964.58%-1.06B
17.82%45.71M
-66.87%175.07M
18.11%48.87M
-9.90%50.32M
-90.52%37.08M
-2.82%38.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-672.50%-1B
-102.22%-1.09M
-69.55%15.32M
-2,964.58%-1.06B
17.82%45.71M
-66.87%175.07M
18.11%48.87M
-9.90%50.32M
-90.52%37.08M
-2.82%38.8M
Basic earnings per share
-670.80%-6.45
-103.13%-0.01
-69.70%0.1
-2,950.00%-6.84
20.00%0.3
-65.34%1.13
28.00%0.32
-2.94%0.33
-90.08%0.24
0.00%0.25
Diluted earnings per share
-771.88%-6.45
-103.70%-0.01
-67.86%0.09
-3,357.14%-6.84
19.05%0.25
-70.09%0.96
8.00%0.27
-17.65%0.28
-91.21%0.21
-16.00%0.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 7.83%442.74M9.66%117.55M4.70%113.74M10.44%107.38M6.70%104.06M-0.76%410.6M-8.48%107.2M4.71%108.64M-6.54%97.23M9.77%97.53M
Operating revenue 7.83%442.74M9.66%117.55M4.70%113.74M10.44%107.38M6.70%104.06M-0.76%410.6M-8.48%107.2M4.71%108.64M-6.54%97.23M9.77%97.53M
Cost of revenue
Gross profit
Operating expense 71.22%274.4M91.43%74.34M71.87%69.03M109.40%87.06M10.79%43.96M-11.72%160.26M-35.85%38.84M3.92%40.16M6.02%41.58M-8.00%39.68M
Selling and administrative expenses 36.48%158.31M36.20%38.67M25.95%36.05M74.23%52.48M7.82%31.12M4.37%115.99M-1.04%28.39M3.16%28.62M11.36%30.12M4.37%28.86M
Research and development costs 162.25%116.09M241.53%35.68M185.71%32.99M201.93%34.58M18.71%12.85M-37.13%44.27M-67.20%10.45M5.85%11.55M-5.85%11.45M-30.11%10.82M
Operating profit -32.76%168.34M-36.79%43.21M-34.71%44.71M-63.49%20.32M3.89%60.1M7.80%250.34M20.80%68.36M5.18%68.47M-14.13%55.66M26.55%57.85M
Net non-operating interest income expense -239.67%-2.66M-284.41%-7.23M-730.63%-8.09M681.75%6.92M372.15%5.75M106.25%1.9M150.44%3.92M116.74%1.28M84.27%-1.19M71.59%-2.11M
Non-operating interest income 99.67%18.97M-78.08%1.19M-37.73%1.75M760.22%8.76M3,061.74%7.27M1,208.68%9.5M2,925.56%5.45M1,476.97%2.81M491.86%1.02M17.35%230K
Non-operating interest expense 184.67%21.63M223.43%9.64M738.58%9.43M-20.70%1.34M-37.64%1.13M-75.61%7.6M-67.58%2.98M-84.83%1.13M-76.90%1.69M-75.04%1.8M
Total other finance cost --------1.50%405K-3.29%499K-25.14%402K---------6.34%399K25.24%516K34.92%537K
Other net income (expense) -612,048.90%-1.11B-31,127.78%-5.62M-3,202.65%-4.69M-161,935.24%-1.1B-97.40%19K116.05%182K99.30%-18K-93.25%151K76.39%-681K-64.89%730K
Gain on sale of security -89.56%19K--0---------97.40%19K115.45%182K99.30%-18K-93.02%151K78.49%-681K-69.46%730K
Special income (charges) ---1.11B---5.62M---4.69M---1.1B------0--0--0--0----
-Less:Restructuring and merger&acquisition --18.32M--621K--4.69M--13.01M------0--0--0--0----
-Less:Other special charges --1.1B--5M------1.09B------------------------
Income before tax -475.59%-948.07M-57.99%30.36M-54.32%31.93M-2,100.97%-1.08B16.64%65.86M25.80%252.42M56.23%72.27M17.15%69.91M-1.08%53.79M39.91%56.47M
Income tax 7.93%83.49M37.21%32.11M-8.21%17.98M-20.65%13.26M14.06%20.15M123.60%77.36M379.37%23.4M411.89%19.59M104.96%16.71M3,988.89%17.66M
Net income -689.24%-1.03B-103.57%-1.75M-72.28%13.95M-3,038.18%-1.09B17.82%45.71M-66.87%175.07M18.11%48.87M-9.90%50.32M-90.52%37.08M-2.82%38.8M
Net income continuous Operations -689.24%-1.03B-103.57%-1.75M-72.28%13.95M-3,038.18%-1.09B17.82%45.71M-66.87%175.07M18.11%48.87M-9.90%50.32M-90.52%37.08M-2.82%38.8M
Minority interest income -29.32M-658K-1.37M-27.29M0000
Net income attributable to the parent company -672.50%-1B-102.22%-1.09M-69.55%15.32M-2,964.58%-1.06B17.82%45.71M-66.87%175.07M18.11%48.87M-9.90%50.32M-90.52%37.08M-2.82%38.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -672.50%-1B-102.22%-1.09M-69.55%15.32M-2,964.58%-1.06B17.82%45.71M-66.87%175.07M18.11%48.87M-9.90%50.32M-90.52%37.08M-2.82%38.8M
Basic earnings per share -670.80%-6.45-103.13%-0.01-69.70%0.1-2,950.00%-6.8420.00%0.3-65.34%1.1328.00%0.32-2.94%0.33-90.08%0.240.00%0.25
Diluted earnings per share -771.88%-6.45-103.70%-0.01-67.86%0.09-3,357.14%-6.8419.05%0.25-70.09%0.968.00%0.27-17.65%0.28-91.21%0.21-16.00%0.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg